… reverse transcriptase inhibitors (NtRTIs). These also target ‘reverse transcriptase’
Protease Inhibitors (PIs). These target the ‘protease’ protein
Entry Inhibitors (these include ‘fusion inhibitors’ and ‘CCR5 antagonists’). These target the point when HIV gets insude CD4 cells
Integrase Inhibitors. These are a new class of drugs that target the integrase protein.
By combining drugs from these classes a number of effective and safe combination regimes …